Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem pharmacokinetics in very low birth weight neonates
2009-017823-24Phase 3Completed
- Sponsor
- Tartu University Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of meropenem in sepsis, pulmonary infection and Intra-abdominal infection (IAI) (2 arms), sponsored by Tartu University Hospital. Primary endpoint: AUC during dosing interval. Started Dec 2009; status: completed.
02
Drugs
meropenem
03
Conditions
sepsispulmonary infectionIntra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2009-017823-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017823-24.